Related Experiment Video
Updated: Jun 10, 2026

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
Published on: November 22, 2024
[Corneal ulcers in systemic autoimmunologic diseases]
R Augsten1, J Dawczynski, U Voigt
1Klinik für Augenheilkunde, Universitätsklinikum Jena, Bachstrasse 18, Jena. Regine.Augsten@med.uni-jena.de
Autoimmune diseases like rheumatoid arthritis can cause severe corneal ulcers, often leading to poor vision. Intensive treatment offers limited improvement, highlighting the need for lifelong immunosuppression to preserve sight.
Area of Science:
- Ophthalmology
- Rheumatology
- Immunology
Background:
- Corneal ulcers are a rare but severe complication of systemic autoimmune diseases.
- Prognosis for these ulcers remains poor despite complex therapeutic interventions.
Observation:
- A study cohort included seven patients (10 eyes) aged 45-73 with corneal ulcers, often perforated, linked to rheumatoid arthritis or Sjögren's syndrome.
- Initial visual acuity varied significantly based on ulcer perforation status.
Findings:
- Surgical interventions (conjunctival plasty, keratoplasty) combined with local and systemic immunosuppressive therapy were employed.
- Despite treatment, visual acuity remained significantly impaired in eyes with perforated ulcers, with some cases requiring evisceration.
- Eyes with non-perforated ulcers showed better visual outcomes with combined therapies.
Implications:
- Corneal ulcers associated with autoimmune conditions pose a significant risk of vision loss, even with aggressive treatment.
- Lifelong systemic immunosuppressive therapy is crucial for managing these conditions and preserving vision in the affected eye.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Nephrotic Syndrome I : Introduction
Peptic Ulcer Disease III: Clinical Manifestations and Complications

